Phlo, the UK based digital pharmacy company, has raised GBP 10m in a series A funding round led by Thairm Bio, the UK based trust, that invests in early-stage life science companies, with participation from Scottish Enterprise, the UK based non-departmental public body of the Scottish Government, and angel investors. This series A fundig is a combination of equity investment and the conversion of existing loan notes.
Target – Phlo Technologies LTD
Buyer – Thairm Bio
Buyer – Scottish enterprise
Buyer – Undisclosed Private investors
Seller – Shareholders